Noema Pharma

Noema Pharma is a clinical-stage biotech company based in the United States. With approximately 11 employees, Noema Pharma is developing a portfolio of disease-transforming therapeutics for central nervous system-mediated conditions, including persistent seizures in tuberous sclerosis complex, severe pain in trigeminal neuralgia, and involuntary tics associated with Tourette syndrome.